Sign in

CIK 0001570562

  • Accelerated filer

Evolus, Inc.

Sign in to watch
Ticker
EOLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
461385614
Phone
+1 949-284-4555
Business address
520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
Former names
Evolus, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$950,019
in 1 filing

Net −$950,019. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MOATAZEDI DAVID −$950K Reporting owner sold 17% of stake
Date Insider Transaction Shares Price Value Owned after
2021-01-27 Jafar Michael M. Grant or award +45,000 219,851
2021-01-25 Jafar Michael M. Sale −2,699 $7.46 $20K 174,851
2020-10-28 Jafar Michael M. Grant or award +48,550 177,550
2020-10-28 Jafar Michael M. Grant or award · Stock Option (Right to Buy) +79,350 79,350
2020-05-13 Jafar Michael M. Chief Marketing Officer Grant or award +40,000 129,000
2020-01-23 Jafar Michael M. Chief Marketing Officer Grant or award +26,000 89,000
2020-01-23 Jafar Michael M. Chief Marketing Officer Grant or award · Stock Option (Right to Buy) +45,000 45,000
2019-01-23 Jafar Michael M. Chief Marketing Officer Grant or award · Stock Option (Right to Buy) +45,000 45,000
2018-09-14 Jafar Michael M. Chief Marketing Officer Purchase +12,800 $20.83 $267K 63,000
2018-06-18 Jafar Michael M. Chief Marketing Officer Grant or award +50,000 50,200
2018-06-18 Jafar Michael M. Chief Marketing Officer Grant or award · Stock Option (Right to Buy) +120,000 120,000

Page 1 of 1 · 11 trades